979. Disparities in PrEP uptake and adherence among cisgender women using a pharmacologic measure

BACKGROUND: HIV pre-exposure prophylaxis (PrEP) is 99% effective at preventing new HIV infections if taken daily. To be successful, PrEP requires concurrent efforts to optimize uptake, persistence, and adherence. In 2018, cisgender (cis) women accounted for 19% of new HIV infections in the US but co...

Descripción completa

Detalles Bibliográficos
Autores principales: Hebel, Shane, Kahn-Woods, Elijah, Enghuus, Casper, Koenig, Helen, Lalley-Chareczko, Linden, Radix, Asa, Daughtridge, Giffin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776913/
http://dx.doi.org/10.1093/ofid/ofaa439.1165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776913/
http://dx.doi.org/10.1093/ofid/ofaa439.1165

Ejemplares similares